ArticleNPJ Parkinson's disease2026
Pesticide exposure and multidomain symptom burden in Parkinson's disease: a longitudinal triangulation study.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although pesticide exposure has been linked to worse motor symptoms in Parkinson's disease (PD), its associations with non-motor burden and with post-diagnostic progression rate remain unclear. We analyzed two large longitudinal cohorts, PPMI Online (n = 7190) and Fox Insight (n = 2298), using linear mixed-effects models and Cox regression, with supportive triangulation in an EHR cohort. In PPMI Online, pesticide exposure was associated with higher MDS-UPDRS Part II scores (β = 1.97, 95% CI 1.34-2.60), lower PDAQ-15 scores (β = -2.40, 95% CI -3.23 to -1.57), and greater anxiety, daytime sleepiness, and sleep disturbance. Motor and cognition-related estimates were directionally similar in Fox Insight. Time interaction estimates showed no consistent exposure-related differences. Primary Cox models indicated earlier motor milestones in both cohorts and earlier sleepiness and anxiety milestones in the PPMI Online cohort. Co-exposure to more pesticide classes was associated with worse motor function in both cohorts. TriNetX also showed elevated risks across five ICD-coded symptom domains (RRs 1.44-1.87), although these findings should be interpreted cautiously because the outcomes were defined differently. Further longitudinal studies using harmonised exposure assessments and repeated multidomain measures are needed to clarify the relationship between pesticide exposure and symptom trajectories after PD diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.